NGM Biopharmaceuticals Competitors and Similar CompaniesClear all
NGM Biopharmaceuticals's competitors and similar companies include Scynexis, vTv Therapeutics, Lixte Biotechnology and Petra Pharma.
 NGM Biopharmaceuticals NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system. |  Scynexis Scynexis is engaged in drug discovery, development and manufacturing projects in various areas. |  vTv Therapeutics vTv Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. |  Lixte Biotechnology Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. |  Petra Pharma Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2000 | Founding Date 1998 | Founding Date 2006 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Jersey City, US HQ | Locations High Point, US HQ High Point, US | Locations East Setauket, US HQ Pasadena, US | Locations New York, US HQ |
Employees | Employees 18622% increase | Employees 3636% decrease | Employees 2650% decrease | Employees 3 | Employees 20 |
Valuation ($) | Valuation ($) 128.5 m | Valuation ($) 53 m | Valuation ($) 35.9 m | Valuation ($) 2.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $4.4m (FY, 2023) | Revenue (est.) $20.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($142.4m) (FY, 2023) | Net income ($8.6m) (FY, 2025) | Net income ($31.1m) (FY, 2025) | Net income ($6m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 11.5m | Total funding raised N/A | Total funding raised $ 1.8m | Total funding raised $ 48m |
For sources of this data, please see the company profile
View Company Profiles
Scynexis
HQ
Jersey City, US
Employees
36↓ 36% decrease
Scynexis is engaged in drug discovery, development and manufacturing projects in various areas.
View companyvTv Therapeutics
HQ
High Point, US
Employees
26↓ 50% decrease
vTv Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs.
View companyLixte Biotechnology
HQ
East Setauket, US
Employees
3
Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets.
View companyPetra Pharma
HQ
New York, US
Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases.
View company